Coagulopathy

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Velico Medical
Velico MedicalMA - Beverly
1 program
1
Autologous Spray Dried PlasmaPhase 11 trial
Active Trials
NCT05629338CompletedEst. Apr 2025
Octapharma
OctapharmaAustria - Vienna
1 program
Octaplas™N/A1 trial
Active Trials
NCT02037373Terminated43Est. Feb 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Velico MedicalAutologous Spray Dried Plasma
OctapharmaOctaplas™

Clinical Trials (2)

Total enrollment: 43 patients across 2 trials

NCT05629338Velico MedicalAutologous Spray Dried Plasma

Ascending Dose Study of FrontlineODP™ Spray Dried Plasma

Start: Dec 2022Est. completion: Apr 2025
Phase 1Completed

Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation

Start: Aug 2015Est. completion: Feb 201843 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space